Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19
Gespeichert in:
| Veröffentlicht in: | Pathology oncology research 2020-10, Vol.26 (4), p.2823-2825 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2825 |
|---|---|
| container_issue | 4 |
| container_start_page | 2823 |
| container_title | Pathology oncology research |
| container_volume | 26 |
| creator | Tsiambas, Evangelos Papanikolaou, Vasileios Chrysovergis, Aristeidis Mastronikolis, Nicholas Ragos, Vasileios Kavantzas, Nikolaos Lazaris, Andreas C. Kyrodimos, Efthymios |
| description | |
| doi_str_mv | 10.1007/s12253-020-00810-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7182393</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2440024461</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-d2352566ce9e680c67378354e87feadf35f7ddd12ca405424725b6633315508f3</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhSMEog_4AyyQJTZlEfDbCQukIQy0UqtuCiwt17lJXXnsYicjTTf8dTydUh4LNral-51zfXSq6gXBbwjG6m0mlApWY4prjBuCa_mo2ieC0Zo2WD0ub0ramrdC7lUHOV_jIpKtfFrtMcoYI227X_3oYorBrF2aM3IBHcPKTNHH0Vl0ZrwbgwnWQX6HLkwaYXJhRGfRg509ZPQBNjH0aLoCtAijixOE7ELdxbCGdMcuw-1mBYiio0W3pK_RN-P9dk93_vXkY03aZ9WTwfgMz-_vw-rLp-VFd1yfnn8-6RanteWKT3VPmaBCSgstyAZbqZhqmODQqAFMPzAxqL7vCbWGY8EpV1RcSrlNKQRuBnZYvd_53syXK-gthCkZr2-SW5m00dE4_fckuCs9xrVWpKGsZcXg6N4gxe8z5EmvXLbgvQkQ56wLxBvVcsEL-uof9DrOKZR4mnKOcTkkKRTdUTbFnBMMD58hWG_71bt-delX3_WrZRG9_DPGg-RXoQVgOyCXURgh_d79H9ufvcKvdQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2440024461</pqid></control><display><type>article</type><title>Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Tsiambas, Evangelos ; Papanikolaou, Vasileios ; Chrysovergis, Aristeidis ; Mastronikolis, Nicholas ; Ragos, Vasileios ; Kavantzas, Nikolaos ; Lazaris, Andreas C. ; Kyrodimos, Efthymios</creator><creatorcontrib>Tsiambas, Evangelos ; Papanikolaou, Vasileios ; Chrysovergis, Aristeidis ; Mastronikolis, Nicholas ; Ragos, Vasileios ; Kavantzas, Nikolaos ; Lazaris, Andreas C. ; Kyrodimos, Efthymios</creatorcontrib><identifier>ISSN: 1219-4956</identifier><identifier>EISSN: 1532-2807</identifier><identifier>DOI: 10.1007/s12253-020-00810-6</identifier><identifier>PMID: 32333199</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>ACE2 ; Angiotensin ; Angiotensin-Converting Enzyme 2 ; Betacoronavirus - genetics ; Betacoronavirus - pathogenicity ; Betacoronavirus - physiology ; Biomarkers ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Coronavirus Infections - complications ; Coronavirus Infections - genetics ; Coronavirus Infections - transmission ; Coronavirus Infections - virology ; Coronaviruses ; COVID-19 ; Hematologic Neoplasms - complications ; Hematologic Neoplasms - physiopathology ; Humans ; Immunocompromised Host ; Immunology ; Letter to the Editor ; Oncology ; Pandemics ; Pathology ; Peptidyl-dipeptidase A ; Peptidyl-Dipeptidase A - genetics ; Pneumonia, Viral - complications ; Pneumonia, Viral - genetics ; Pneumonia, Viral - transmission ; Pneumonia, Viral - virology ; Polymorphism, Single Nucleotide ; SARS-CoV-2</subject><ispartof>Pathology oncology research, 2020-10, Vol.26 (4), p.2823-2825</ispartof><rights>Arányi Lajos Foundation 2020</rights><rights>Arányi Lajos Foundation 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-d2352566ce9e680c67378354e87feadf35f7ddd12ca405424725b6633315508f3</citedby><cites>FETCH-LOGICAL-c474t-d2352566ce9e680c67378354e87feadf35f7ddd12ca405424725b6633315508f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12253-020-00810-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12253-020-00810-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32333199$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsiambas, Evangelos</creatorcontrib><creatorcontrib>Papanikolaou, Vasileios</creatorcontrib><creatorcontrib>Chrysovergis, Aristeidis</creatorcontrib><creatorcontrib>Mastronikolis, Nicholas</creatorcontrib><creatorcontrib>Ragos, Vasileios</creatorcontrib><creatorcontrib>Kavantzas, Nikolaos</creatorcontrib><creatorcontrib>Lazaris, Andreas C.</creatorcontrib><creatorcontrib>Kyrodimos, Efthymios</creatorcontrib><title>Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19</title><title>Pathology oncology research</title><addtitle>Pathol. Oncol. Res</addtitle><addtitle>Pathol Oncol Res</addtitle><subject>ACE2</subject><subject>Angiotensin</subject><subject>Angiotensin-Converting Enzyme 2</subject><subject>Betacoronavirus - genetics</subject><subject>Betacoronavirus - pathogenicity</subject><subject>Betacoronavirus - physiology</subject><subject>Biomarkers</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Coronavirus Infections - complications</subject><subject>Coronavirus Infections - genetics</subject><subject>Coronavirus Infections - transmission</subject><subject>Coronavirus Infections - virology</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Hematologic Neoplasms - complications</subject><subject>Hematologic Neoplasms - physiopathology</subject><subject>Humans</subject><subject>Immunocompromised Host</subject><subject>Immunology</subject><subject>Letter to the Editor</subject><subject>Oncology</subject><subject>Pandemics</subject><subject>Pathology</subject><subject>Peptidyl-dipeptidase A</subject><subject>Peptidyl-Dipeptidase A - genetics</subject><subject>Pneumonia, Viral - complications</subject><subject>Pneumonia, Viral - genetics</subject><subject>Pneumonia, Viral - transmission</subject><subject>Pneumonia, Viral - virology</subject><subject>Polymorphism, Single Nucleotide</subject><subject>SARS-CoV-2</subject><issn>1219-4956</issn><issn>1532-2807</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtv1DAUhSMEog_4AyyQJTZlEfDbCQukIQy0UqtuCiwt17lJXXnsYicjTTf8dTydUh4LNral-51zfXSq6gXBbwjG6m0mlApWY4prjBuCa_mo2ieC0Zo2WD0ub0ramrdC7lUHOV_jIpKtfFrtMcoYI227X_3oYorBrF2aM3IBHcPKTNHH0Vl0ZrwbgwnWQX6HLkwaYXJhRGfRg509ZPQBNjH0aLoCtAijixOE7ELdxbCGdMcuw-1mBYiio0W3pK_RN-P9dk93_vXkY03aZ9WTwfgMz-_vw-rLp-VFd1yfnn8-6RanteWKT3VPmaBCSgstyAZbqZhqmODQqAFMPzAxqL7vCbWGY8EpV1RcSrlNKQRuBnZYvd_53syXK-gthCkZr2-SW5m00dE4_fckuCs9xrVWpKGsZcXg6N4gxe8z5EmvXLbgvQkQ56wLxBvVcsEL-uof9DrOKZR4mnKOcTkkKRTdUTbFnBMMD58hWG_71bt-delX3_WrZRG9_DPGg-RXoQVgOyCXURgh_d79H9ufvcKvdQ</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Tsiambas, Evangelos</creator><creator>Papanikolaou, Vasileios</creator><creator>Chrysovergis, Aristeidis</creator><creator>Mastronikolis, Nicholas</creator><creator>Ragos, Vasileios</creator><creator>Kavantzas, Nikolaos</creator><creator>Lazaris, Andreas C.</creator><creator>Kyrodimos, Efthymios</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201001</creationdate><title>Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19</title><author>Tsiambas, Evangelos ; Papanikolaou, Vasileios ; Chrysovergis, Aristeidis ; Mastronikolis, Nicholas ; Ragos, Vasileios ; Kavantzas, Nikolaos ; Lazaris, Andreas C. ; Kyrodimos, Efthymios</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-d2352566ce9e680c67378354e87feadf35f7ddd12ca405424725b6633315508f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>ACE2</topic><topic>Angiotensin</topic><topic>Angiotensin-Converting Enzyme 2</topic><topic>Betacoronavirus - genetics</topic><topic>Betacoronavirus - pathogenicity</topic><topic>Betacoronavirus - physiology</topic><topic>Biomarkers</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Coronavirus Infections - complications</topic><topic>Coronavirus Infections - genetics</topic><topic>Coronavirus Infections - transmission</topic><topic>Coronavirus Infections - virology</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Hematologic Neoplasms - complications</topic><topic>Hematologic Neoplasms - physiopathology</topic><topic>Humans</topic><topic>Immunocompromised Host</topic><topic>Immunology</topic><topic>Letter to the Editor</topic><topic>Oncology</topic><topic>Pandemics</topic><topic>Pathology</topic><topic>Peptidyl-dipeptidase A</topic><topic>Peptidyl-Dipeptidase A - genetics</topic><topic>Pneumonia, Viral - complications</topic><topic>Pneumonia, Viral - genetics</topic><topic>Pneumonia, Viral - transmission</topic><topic>Pneumonia, Viral - virology</topic><topic>Polymorphism, Single Nucleotide</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsiambas, Evangelos</creatorcontrib><creatorcontrib>Papanikolaou, Vasileios</creatorcontrib><creatorcontrib>Chrysovergis, Aristeidis</creatorcontrib><creatorcontrib>Mastronikolis, Nicholas</creatorcontrib><creatorcontrib>Ragos, Vasileios</creatorcontrib><creatorcontrib>Kavantzas, Nikolaos</creatorcontrib><creatorcontrib>Lazaris, Andreas C.</creatorcontrib><creatorcontrib>Kyrodimos, Efthymios</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pathology oncology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsiambas, Evangelos</au><au>Papanikolaou, Vasileios</au><au>Chrysovergis, Aristeidis</au><au>Mastronikolis, Nicholas</au><au>Ragos, Vasileios</au><au>Kavantzas, Nikolaos</au><au>Lazaris, Andreas C.</au><au>Kyrodimos, Efthymios</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19</atitle><jtitle>Pathology oncology research</jtitle><stitle>Pathol. Oncol. Res</stitle><addtitle>Pathol Oncol Res</addtitle><date>2020-10-01</date><risdate>2020</risdate><volume>26</volume><issue>4</issue><spage>2823</spage><epage>2825</epage><pages>2823-2825</pages><issn>1219-4956</issn><eissn>1532-2807</eissn><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>32333199</pmid><doi>10.1007/s12253-020-00810-6</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1219-4956 |
| ispartof | Pathology oncology research, 2020-10, Vol.26 (4), p.2823-2825 |
| issn | 1219-4956 1532-2807 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7182393 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | ACE2 Angiotensin Angiotensin-Converting Enzyme 2 Betacoronavirus - genetics Betacoronavirus - pathogenicity Betacoronavirus - physiology Biomarkers Biomedical and Life Sciences Biomedicine Cancer Research Coronavirus Infections - complications Coronavirus Infections - genetics Coronavirus Infections - transmission Coronavirus Infections - virology Coronaviruses COVID-19 Hematologic Neoplasms - complications Hematologic Neoplasms - physiopathology Humans Immunocompromised Host Immunology Letter to the Editor Oncology Pandemics Pathology Peptidyl-dipeptidase A Peptidyl-Dipeptidase A - genetics Pneumonia, Viral - complications Pneumonia, Viral - genetics Pneumonia, Viral - transmission Pneumonia, Viral - virology Polymorphism, Single Nucleotide SARS-CoV-2 |
| title | Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T18%3A25%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coronavirus%20in%20Hematologic%20Malignancies:%20Targeting%20Molecules%20Beyond%20the%20Angiotensin-Converting%20Enzyme%202%20(ACE2)%20Wall%20in%20COVID-19&rft.jtitle=Pathology%20oncology%20research&rft.au=Tsiambas,%20Evangelos&rft.date=2020-10-01&rft.volume=26&rft.issue=4&rft.spage=2823&rft.epage=2825&rft.pages=2823-2825&rft.issn=1219-4956&rft.eissn=1532-2807&rft_id=info:doi/10.1007/s12253-020-00810-6&rft_dat=%3Cproquest_pubme%3E2440024461%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2440024461&rft_id=info:pmid/32333199&rfr_iscdi=true |